BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15104218)

  • 1. Relationship between cathepsin B, cathepsin D expression and biological behaviour in mucinous colorectal carcinoma.
    Wang Y; Lin X
    Chin Med Sci J; 2004 Mar; 19(1):12. PubMed ID: 15104218
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D.
    van der Stappen JW; Williams AC; Maciewicz RA; Paraskeva C
    Int J Cancer; 1996 Aug; 67(4):547-54. PubMed ID: 8759615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters.
    Adenis A; Huet G; Zerimech F; Hecquet B; Balduyck M; Peyrat JP
    Cancer Lett; 1995 Sep; 96(2):267-75. PubMed ID: 7585467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine protease activities and tumor development in human colorectal carcinoma.
    Sheahan K; Shuja S; Murnane MJ
    Cancer Res; 1989 Jul; 49(14):3809-14. PubMed ID: 2544258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
    Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
    Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cathepsin D and B in invasion and metastasis of squamous cell carcinoma.
    Kawada A; Hara K; Kominami E; Hiruma M; Akiyama M; Ishibashi A; Abe H; Ichikawa E; Nakamura Y; Watanabe S; Yamamoto T; Umeda T; Nishioka K
    Br J Dermatol; 1997 Sep; 137(3):361-6. PubMed ID: 9349330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of cathepsin D in colorectal tumors.
    Arao J; Fukui H; Ono Y; Ueda Y; Chiba T; Fujimori T
    Dis Colon Rectum; 2000 Mar; 43(3):396-401. PubMed ID: 10733123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
    Bedner E; Harezga B; Osborn M; Domagała W
    Pol J Pathol; 1995; 46(1):11-5. PubMed ID: 7780691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cathepsin D activity in gastric cancer].
    Kantsaliev AL; Kozyreva EA; Kushlinskiĭ NE; Rottenberg VI; Klimenkov AA; Vasil'ev AV
    Vopr Onkol; 1994; 40(1-3):40-6. PubMed ID: 7701792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of cathepsin B and D in physiologic and pathologic processes].
    Olszewska D; Drewa T; Makarewicz R; Drewa J; Woźniak A; Maciak R
    Pol Merkur Lekarski; 2001 Jan; 10(55):65-70. PubMed ID: 11320558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1 and cathepsin D expression in early colorectal carcinoma showing V type pit pattern.
    Nagata S; Tanaka S; Haruma K; Kitadai Y; Yoshihara M; Shimamoto F; Kohno N; Chayama K
    Int J Oncol; 2001 Oct; 19(4):665-72. PubMed ID: 11562739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The activity of cathepsin B in colorectal adenocarcinomas].
    Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Sulkowski S; Chrzanowska A
    Pol Merkur Lekarski; 2001 Oct; 11(64):330-3. PubMed ID: 11770313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of phospholipase D2 in human colorectal carcinoma.
    Saito M; Iwadate M; Higashimoto M; Ono K; Takebayashi Y; Takenoshita S
    Oncol Rep; 2007 Nov; 18(5):1329-34. PubMed ID: 17914593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
    Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
    Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
    Murthy RV; Arbman G; Gao J; Roodman GD; Sun XF
    Clin Cancer Res; 2005 Mar; 11(6):2293-9. PubMed ID: 15788679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.
    Iacobuzio-Donahue C; Shuja S; Cai J; Peng P; Willett J; Murnane MJ
    Int J Oncol; 2004 Mar; 24(3):473-85. PubMed ID: 14767531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
    Miyoshi N; Ishii H; Mimori K; Tanaka F; Hitora T; Tei M; Sekimoto M; Doki Y; Mori M
    Ann Surg Oncol; 2010 Apr; 17(4):967-72. PubMed ID: 20033322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinoma.
    Khan A; Krishna M; Baker SP; Banner BF
    Mod Pathol; 1998 Aug; 11(8):704-8. PubMed ID: 9720496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin D activity in colorectal cancer.
    Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
    Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.